Novartis Investigative Site

Blackburn, Lancashire BB2 3HH

0 studies enrolling now · 2 studies all time

What they study most

Acute Heart Failure, Metastatic Breast Cancer

Studies at this site

• A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi — Stopped early
• Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF — Completed